519 results
PCR's Got Talent Round 1 - Session 1
20 May 2025 – From EuroPCR 2025
Experience a diverse range of cutting-edge interventional cardiology topics in PCR's Got Talent Round 1. This session features presentations on PFO closure outcomes, plaque morphology, vascular injury treatments, microvascular disease assessment, TAVI-related coronary obstruction prediction, novel FFR surrogates, and more.
What is new in atrioventricular valves?
19 May 2025 – From EuroPCR 2025
Discover the latest advancements in atrioventricular valve interventions, including innovative transcatheter repair technologies and first-in-human experiences with novel devices.
New solutions for old problems
19 May 2025 – From EuroPCR 2025
Discover new solutions addressing persistent cardiovascular challenges, including novel diagnostic systems, vascular closure devices, specialized transcatheter closure technologies, and innovative stent-graft systems.
Quadruple pulmonary vein stenting for post-ablation stenosis
28 Apr 2025
Watch this EuroIntervention image to discover how a complex case of severe pulmonary vein stenosis after atrial fibrillation ablation was successfully managed with multi-stent implantation and intravascular imaging guidance — restoring the patient’s quality of life almost immediately.
Pacemaker leads and tricuspid interventions: knowns and unknowns
24 Apr 2025
Watch this webinar with F. Praz, J-C. Deharo, J. Dreyfus and B. Mondésert and learn about the mechanisms and risk of interaction between pacemaker lead and the tricuspid valve, and much more!
Updates in tricuspid interventions: from the procedure to follow-up
15 Apr 2025
Watch the replay of this webinar with G. Nickenig, J. Dreyfus, S. Kar and P. Lurz and learn about the follow-up results of the TRILUMINATE trial, and so much more!
Primary tricuspid regurgitation: how can we avoid high-risk surgery?
08 Apr 2025
A 70-year-old male patient presents with severe dyspnea (NYHA III) and marked leg edema, alongside a complex medical history including hypertrophic cardiomyopathy, pulmonary hypertension, and liver fibrosis.
With invasive hemodynamic measurements indicating elevated pressures and reduced cardiac output, how would you approach the treatment of this patient,...

Author

Author
Two-year outcomes of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation: The Triluminate pivotal trial
02 Apr 2025
Alex Sticchi interviews Saibal Kar about the two-year results of the Triluminate pivotal trial, unveiled at ACC.25 in Chicago.
After revisiting the one-year findings and outlining the study design, Saibal Kar highlights key takeaways: at two years, TriClip therapy significantly reduced heart failure hospitalisations compared to medical...
Author

Author

Author
Gore Cardioform ASD occluder implantation for late progression of TR after Triclip
12 Mar 2025
Late progression of TR following T-TEER is not uncommon and may be challenging to treat due to anatomical and technical limitations. This is the 1st report of Gore Cardioform ASD Occluder implantation to treat recurrent severe TR after T-TEER.